dehydroascorbic acid has been researched along with Cancer of Prostate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Brożyna, AA; Foksinski, M; Linowiecka, K | 1 |
Keshari, KR; Kurhanewicz, J; Sai, V; Vanbrocklin, HF; Wang, ZJ; Wilson, DM | 1 |
Aigner, A; Czubayko, F; Frömberg, A; Gutsch, D; Schulze, D; Vollbracht, C; Weiss, G | 1 |
1 review(s) available for dehydroascorbic acid and Cancer of Prostate
Article | Year |
---|---|
Vitamin C Transporters and Their Implications in Carcinogenesis.
Topics: Ascorbic Acid; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Breast Neoplasms; Carcinogenesis; Dehydroascorbic Acid; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Female; Glioma; Glucose Transport Proteins, Facilitative; Hematologic Neoplasms; Homeostasis; Humans; Hypoxia-Inducible Factor 1; Ketoglutaric Acids; Male; Melanoma; Mixed Function Oxygenases; Neoplasms; Oxidation-Reduction; Polymorphism, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins; Sodium-Coupled Vitamin C Transporters; Vitamins | 2020 |
2 other study(ies) available for dehydroascorbic acid and Cancer of Prostate
Article | Year |
---|---|
Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET.
Topics: Animals; Biological Transport; Dehydroascorbic Acid; Disease Models, Animal; Fluorodeoxyglucose F18; Magnetic Resonance Spectroscopy; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms | 2013 |
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.
Topics: Antineoplastic Agents; Apoptosis; Ascorbic Acid; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dehydroascorbic Acid; Docetaxel; Drug Synergism; Epirubicin; Humans; Irinotecan; Male; Organoplatinum Compounds; Oxaliplatin; Prostatic Neoplasms; Taxoids; Vinblastine; Vinorelbine | 2011 |